The global metagenomics market share is expanding as genomic sequencing technologies gain wider application across healthcare, pharmaceutical research, agriculture, and environmental monitoring. According to Fortune Business Insights, the global metagenomics market size was valued at USD 2.99 billion in 2025. The market is projected to grow from USD 3.40 billion in 2026 to USD 9.52 billion by 2034, exhibiting a CAGR of 13.73% during the forecast period.

Metagenomics is the study of genetic material recovered directly from environmental or biological samples. Unlike conventional methods that require individual microorganisms to be cultured, this approach enables researchers to examine microbial communities collectively. It helps identify microorganisms, investigate microbial diversity, and understand the functions of genes within complex communities. These capabilities make metagenomics valuable for microbiome research, infectious disease detection, drug discovery, and environmental studies.

Growing interest in the human microbiome and the increasing use of next-generation sequencing are supporting the adoption of metagenomic technologies. Researchers are using these methods to study microbial interactions, investigate antimicrobial resistance, and identify potential applications in precision healthcare. The technology is also gaining attention in agricultural biotechnology, food safety, and wastewater monitoring, creating opportunities across multiple industries.

Top Companies In The Market

Leading companies in the global metagenomics market are focusing on sequencing technologies, laboratory products, and genomic analysis solutions. The major companies include:

• Bio-Rad Laboratories, Inc.

• Illumina, Inc.

• PerkinElmer, Inc.

• Thermo Fisher Scientific, Inc.

• Novogene Co., Ltd.

• Promega Corporation

• QIAGEN

• Takara Bio, Inc.

• Oxford Nanopore Technologies

• Hoffmann-La Roche Ltd.

Market Drivers & Restraints:

Growing microbiome research: Increasing research into microbial communities is supporting demand for metagenomic sequencing. Researchers are examining the relationship between microorganisms and human health, including their potential roles in gastrointestinal conditions, immune responses, and other diseases. Metagenomics enables the analysis of complex microbial populations and supports investigations into microbial diversity and function. Pharmaceutical and biotechnology companies are also exploring microbiome-based therapeutic development, further supporting the use of these technologies.

Expansion of infectious disease surveillance: The growing need to identify pathogens and monitor antimicrobial resistance is encouraging the use of metagenomic methods. These technologies can help researchers detect microorganisms in complex samples and investigate emerging infectious threats. Their use in public health surveillance and environmental monitoring is creating additional demand for sequencing platforms and related analytical solutions.

High sequencing and data analysis costs: The adoption of metagenomics can be restricted by the cost of sequencing instruments, consumables, computational infrastructure, and data storage. Smaller laboratories and research institutions may face budget limitations when implementing high-throughput sequencing workflows. The need for specialized bioinformatics expertise also adds to operational expenses.

Complexity of genomic data interpretation: Metagenomic studies generate large datasets that require advanced analytical tools and reliable reference databases. Differences in sample preparation, sequencing procedures, and bioinformatics pipelines can affect consistency and reproducibility. These factors create challenges for laboratories seeking standardized results, particularly in clinical applications.

Market Competitive Landscape:

The competitive landscape includes sequencing technology providers, laboratory equipment manufacturers, and companies offering genomic analysis products and services. Market participants are working to improve sequencing performance, simplify sample preparation, and strengthen the interpretation of complex microbial datasets. Product development in sequencing instruments, consumables, reagents, and bioinformatics solutions remains important to industry competition.

Market Segments:

The global metagenomics market is segmented

By Technology (Shotgun Sequencing, Whole Genome Sequencing)

By Product, By Workflow, By Application

Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/metagenomics-market-116247 

Market Regional Insights:

North America: North America dominated the global metagenomics market with approximately 39% of the market share in 2025. The region benefits from established genomic research infrastructure and the adoption of advanced sequencing technologies. The U.S. is an important contributor, supported by microbiome-focused research, precision medicine initiatives, and genomic surveillance programs. Collaboration among pharmaceutical companies, biotechnology firms, and academic institutions is also supporting market development.

Europe: Europe accounted for approximately 28% of the global market. Countries such as Germany, the U.K., France, and the Netherlands contribute to regional demand through genomic research, clinical sequencing, and public health initiatives. The use of metagenomics in pathogen identification, environmental monitoring, and microbiome studies supports adoption across the region.

Asia Pacific: Asia Pacific represented approximately 26% of the global market. Increasing investment in biotechnology, expanding genomic research infrastructure, and growing interest in microbiome studies are supporting regional development. Japan, China, India, and South Korea are important markets. Applications in infectious disease surveillance, agricultural biotechnology, and clinical research are contributing to demand.

Future Market Scope:

The future of the metagenomics market will be shaped by developments in sequencing technologies, bioinformatics, and microbiome research. Increasing use of shotgun sequencing is expected to support more comprehensive analysis of microbial communities. Improvements in sequencing workflows may also help researchers process samples more efficiently and obtain detailed information about microbial composition and function. Artificial intelligence, automated bioinformatics, and cloud-based genomic analysis are becoming important areas of technological development. These tools can help researchers manage large datasets, improve microbial identification, and simplify genomic interpretation. Portable sequencing systems and real-time monitoring technologies may further expand applications in infectious disease surveillance and environmental research.

Curious About Japan’s Market? Explore the Latest -Metagenomics Market- Insights